Terms: = Germ cell tumor AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Prognosis
36 results:
1. Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study.
Tao Z; Deng X; Ding Z; Guo B; Fan Y
Front Endocrinol (Lausanne); 2024; 15():1433329. PubMed ID: 39268233
[TBL] [Abstract] [Full Text] [Related]
2. E-cadherin expression and gene expression profiles in corticotroph pituitary neuroendocrine tumor subtypes.
Kiseljak-Vassiliades K; Lipe K; Turin CG; Fishbein L; Costello JC; Kerr JM; Holmstoen TB; Youssef AS; Lillehei KO; Kleinschmidt-DeMasters BK; Wierman ME
J Neuropathol Exp Neurol; 2024 Jun; 83(7):586-595. PubMed ID: 38777808
[TBL] [Abstract] [Full Text] [Related]
3. Racial and ethnic minorities in lower income brackets are associated with late-stage diagnosis of non-ocular melanoma.
Joshi P; Ogobuiro I; Hernandez A; De La Cruz Ku G; Noe DG; Feun L; Liu ZJ; Möller MG
Cancer Epidemiol; 2023 Dec; 87():102489. PubMed ID: 37979223
[TBL] [Abstract] [Full Text] [Related]
4. cdh1 hypermethylation: a potential molecular pathway for invasiveness in glioblastoma.
Belut DR; Lima EO; Zanini MA; Galvani AF; Furtado FB; Ferrasi AC
Eur J Cancer Prev; 2024 Jan; 33(1):73-btii. PubMed ID: 37401481
[TBL] [Abstract] [Full Text] [Related]
5. Decoding molecular programs in melanoma brain metastases.
Radke J; Schumann E; Onken J; Koll R; Acker G; Bodnar B; Senger C; Tierling S; Möbs M; Vajkoczy P; Vidal A; Högler S; Kodajova P; Westphal D; Meier F; Heppner F; Kreuzer-Redmer S; Grebien F; Jürchott K; Redmer T
Nat Commun; 2022 Nov; 13(1):7304. PubMed ID: 36435874
[TBL] [Abstract] [Full Text] [Related]
6. Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated cell Adhesion Molecules in Uveal Melanoma.
Baqai U; Purwin TJ; Bechtel N; Chua V; Han A; Hartsough EJ; Kuznetsoff JN; Harbour JW; Aplin AE
Mol Cancer Res; 2022 Aug; 20(8):1260-1271. PubMed ID: 35426938
[TBL] [Abstract] [Full Text] [Related]
7. [Value of tumor growth rate in evaluating the early therapeutic efficacy of neuroendocrine neoplasm].
Zhou YT; Xia YF; Li Y; Zhu YJ; Chi Y; Jiang L
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1000-1006. PubMed ID: 35399019
[No Abstract] [Full Text] [Related]
8. Magnetic resonance imaging indicators for neurological outcome after surgery in patients with intramedullary spinal ependymomas.
Ma Y; Bai B; Zhao X; Wang L; Zhao B; Guo Y; Yin H; Zhang X; Zheng Z
Medicine (Baltimore); 2022 Jan; 101(4):e28682. PubMed ID: 35089217
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of chemokine receptor CXCR4 predicts lymph node metastatic risk in patients with melanoma: A systematic review and meta-analysis.
Alimohammadi M; Rahimi A; Faramarzi F; Alizadeh-Navaei R; Rafiei A
Cytokine; 2021 Dec; 148():155691. PubMed ID: 34464923
[TBL] [Abstract] [Full Text] [Related]
10. A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival.
Valiulyte I; Steponaitis G; Kardonaite D; Tamasauskas A; Kazlauskas A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036421
[TBL] [Abstract] [Full Text] [Related]
11. cellular Phenotypic Plasticity of Cutaneous Melanoma: A Complex Puzzle.
Joshi SS; Hornyak TJ
J Invest Dermatol; 2020 Apr; 140(4):743-745. PubMed ID: 32200877
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.
Kowalik A; Jurkowska M; Mierzejewska E; Ługowska I; Gos A; Szumera-Ciećkiewicz A; Zięba S; Koseła-Paterczyk H; van der Oord J; Dębiec-Rychter M; Szamotulska K; Siedlecki J; Rutkowski P
Melanoma Res; 2020 Aug; 30(4):348-357. PubMed ID: 32073511
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis.
Trigg RM; Turner SD; Shaw JA; Jahangiri L
Br J Cancer; 2020 Mar; 122(7):1077-1084. PubMed ID: 32015512
[TBL] [Abstract] [Full Text] [Related]
14. Epithelial-to-mesenchymal transition-related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis.
Malgulwar PB; Nambirajan A; Pathak P; Rajeshwari M; Suri V; Sarkar C; Singh M; Sharma MC
Hum Pathol; 2018 Dec; 82():149-157. PubMed ID: 30067950
[TBL] [Abstract] [Full Text] [Related]
15. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract] [Full Text] [Related]
16. Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and prognosis of Adamantinomatous Craniopharyngiomas.
Jucá CEB; Colli LM; Martins CS; Campanini ML; Paixão B; Jucá RV; Saggioro FP; de Oliveira RS; Moreira AC; Machado HR; Neder L; Antonini SR; de Castro M
Horm Metab Res; 2018 Jul; 50(7):575-581. PubMed ID: 29625497
[No Abstract] [Full Text] [Related]
17. Overexpression of CPEB4 in glioma indicates a poor prognosis by promoting cell migration and invasion.
Zhijun L; Dapeng W; Hong J; Guicong W; Bingjian Y; Honglin L
Tumour Biol; 2017 Apr; 39(4):1010428317694538. PubMed ID: 28381179
[TBL] [Abstract] [Full Text] [Related]
18. Significance of the Complete Surgical Staging of Stage I Malignant Ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Ann Surg Oncol; 2016 Sep; 23(9):2982-7. PubMed ID: 27112586
[TBL] [Abstract] [Full Text] [Related]
19. Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms.
Kaltenborn A; Matzke S; Kleine M; Krech T; Ramackers W; Vondran FW; Klempnauer J; Bektas H; Schrem H
J Surg Oncol; 2016 Feb; 113(2):194-202. PubMed ID: 26709239
[TBL] [Abstract] [Full Text] [Related]
20. ST3GAL1-Associated Transcriptomic Program in Glioblastoma tumor Growth, Invasion, and prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract] [Full Text] [Related]
[Next]